745775-31-9 Usage
Uses
Used in Pharmaceutical Synthesis:
3-AMINO-3-(3-ISOPROPOXYPHENYL)PROPANOIC ACID is utilized as a key intermediate in the creation of cardiovascular and central nervous system drugs, playing a pivotal role in the development of medications that address critical health concerns.
Used in Organic Compound Production:
3-AMINO-3-(3-ISOPROPOXYPHENYL)PROPANOIC ACID also functions as an intermediate in the synthesis of other organic compounds, highlighting its versatility and importance in organic chemistry and related industries.
Used in Research and Development:
3-AMINO-3-(3-ISOPROPOXYPHENYL)PROPANOIC ACID is employed in the field of medicinal chemistry for research and development purposes, facilitating the discovery and innovation of new pharmaceutical agents and治疗方法.
Check Digit Verification of cas no
The CAS Registry Mumber 745775-31-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,5,7,7 and 5 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 745775-31:
(8*7)+(7*4)+(6*5)+(5*7)+(4*7)+(3*5)+(2*3)+(1*1)=199
199 % 10 = 9
So 745775-31-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO3/c1-8(2)16-10-5-3-4-9(6-10)11(13)7-12(14)15/h3-6,8,11H,7,13H2,1-2H3,(H,14,15)
745775-31-9Relevant academic research and scientific papers
DIAMINOPROPANE DERIVED MACROCYCLES AS INHIBITORS OF BETA AMYLOID PRODUCTION
-
Page/Page column 37, (2008/12/07)
There is provided a series of macrocyclic diaminopropanes of Formula (I) or a stereoisomer; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, m, n, W, X, Y, Z and L as defined herein, their pharmaceutical compositions and methods of use. These novel compounds inhibit the processing of amyloid precursor protein (APP) by β-secretase and, more specifically, inhibit the production of Aβ-peptide. The present disclosure is directed to compounds useful in the treatment of neurological disorders related to β-amyloid production, such as Alzheimer's disease and other conditions affected by anti-amyloid activity.
